Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Prenetics Sees Q1 Revenue $11.5M-$13M Vs $11.2M Est.; FY25 Revenue $73M-$85M Vs $75.4M Est.

Author: Benzinga Newsdesk | March 05, 2025 09:38am

For the first quarter of 2025, we expect consumer results to be:

  • Revenue of $11.5 million to $13 million
    • IM8: $4.0 million to $4.5 million
    • Europa: $5.0 million to $5.5 million
    • CircleDNA: $2.5 million to $3.0 million
  • Adjusted EBITDA loss: $(5.5) million to $(6.0) million

For the full year 2025, we expect consumer results to be:

  • Revenue of $73 million to $85 million
    • IM8: $30 million to $35 million
    • Europa: $30 million to $35 million
    • CircleDNA: $13 million to $15 million
  • Adjusted EBITDA loss: $(13) million to $(15) million
  • Q4 2025: Adjusted EBITDA profitable

Posted In: PRE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist